Fintepla + Quercetin

 Here's what the current research suggests

Fintepla interactions: Fintepla is metabolized by CYP1A2, CYP2B6, CYP2D6, CYP2C9, CYP2C19, and CYP3A4/5 enzymes. It is also known to interact with certain antidepressants (SSRIs, SNRIs, TCAs, and MAOIs) and other substances like St. John's Wort that affect serotonin levels, potentially increasing the risk of serotonin syndrome.

Quercetin effects: Quercetin can inhibit the activity of certain CYP enzymes, including CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. 

Comments

Popular posts from this blog

One door closed, another opened: Stoke vs. MT-APP6

gastric stasis

“Don’t let your child’s diagnosis become your personality” Poem